Articles

Pharma industry pow-wows: Waiting on the smoke signal

Once cross-industry pharma consortiums announce their presence and pledge to continue meeting, we don’t hear much from them. We sit, waiting for the plume of white smoke to emerge, but the skies are still clear for now.
Written byAmy Swinderman
| 3 min read

In recent months, we've reported quite a bit oninterdisciplinary consortiums, or groups of industry players that temporarilyagree to forget that they are gunning for the same market share in order tocome together, identify problems and pledge to work together to create solutions.So it was no great surprise to me this month when an e-mail arrived announcingthe inaugural meeting of yet another such cross-industry group.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.